BIOLENS: Corneal Biomechanics and Continuous IOP Monitoring Using Soft Contact Lenses in Glaucomatous Patients

Sponsor
University Hospital, Bordeaux (Other)
Overall Status
Completed
CT.gov ID
NCT01849536
Collaborator
(none)
30
1
1
9
3.3

Study Details

Study Description

Brief Summary

Ocular hypertension and its fluctuations is a major risk factor of glaucoma onset and progression. In normal eyes, IOP presents a circadian rhythm, but in glaucomatous eyes IOP circadian rhythm is altered and varied widely between patients. To date, the only way to evaluate 24 hour IOP fluctuations is a regular GAT-IOP measurement during a 24-hour hospitalization. This method is expensive and does not reflect physiological conditions because it requires IOP measurements during sleeping periods that may potentially produce artifacts.

Sensimed AG has developed a new medical device SENSIMED Triggerfish® that enables a 24-hour continuous monitoring of IOP fluctuations. As any IOP measurements methods, this medical device might be influenced by corneal properties of the cornea as central corneal thickness, keratometry or biomechanics. We, therefore, investigate the corneal lens tolerance, potential modifications of corneal parameters after a 24-hour wear of the lens, and its influence on data collected during the whole period of analysis. Then we will also analyze the influence of corneal parameters on continuous IOP fluctuations measured with the contact sensor and finally the correlation between data collected and the rate of progression (severity) of glaucoma evaluated with visual field test or optic nerve head damages.

Condition or Disease Intervention/Treatment Phase
  • Device: SENSIMED Triggerfish®
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Corneal Biomechanics and Continuous IOP Monitoring Using Soft Contact Lenses in Glaucomatous Patients
Study Start Date :
Jan 1, 2013
Actual Primary Completion Date :
Oct 1, 2013
Actual Study Completion Date :
Oct 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: SENSIMED Triggerfish®

SENSIMED Triggerfish®

Device: SENSIMED Triggerfish®

Outcome Measures

Primary Outcome Measures

  1. Corneal biomechanics influence on IOP fluctuation. [24h]

    To evaluate corneal biomechanics influence on IOP fluctuation using SENSIMED Triggerfish® for glaucoma patients with a progressive visual field.

Secondary Outcome Measures

  1. Correlation between visual field defects and IOP fluctuations measurements. [24h]

    To evaluate the correlation between visual field defects and IOP fluctuations measurements.

  2. Correlation between the severity of optic nerve head damages and IOP. fluctuations measurements [24h]

    To evaluate the correlation between the severity of optic nerve head damages measured with OCT and IOP fluctuations measurements.

  3. Lens tolerance and corneal parameters after 24-hours of contact lens wear. [24h]

    To evaluate lens tolerance and corneal parameters after 24-hours of contact lens wear (Pachymetry, Corneal hysteresis and Keratometry ).

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • At least 40 year-old

  • Signed informed consent

  • Visual field defect : at least 2 visual field already done, only the second one is considered for the visual field defect diagnosis, using theses criterion:

  • 3 adjacent points with at least 5db loss

  • Or 1 point with at least 10 db loss

  • Or a 10db difference between two adjacent points on either sides of the nasal horizontal meridian

  • Open angle glaucoma patients with a progressive visual field

  • For women of childbearing potential, adequate contraception

Exclusion Criteria:
  • Corneal dystrophy, scars or corneal surgery

  • Iridocorneal angle opening less than 3 using Shaeffer classification

  • History of glaucoma surgery

  • Any contraindications with the SENSIMED Triggerfish® device, as written in the user manual (active eye disease, severe dry eye, contraindications for silicone contact lens wear…)

  • Diabetes

  • Sleep Apnea Syndromes

  • Cataract surgery

  • High myopia

  • Pregnancy and lactation

  • Patients not able to understand the character and individual consequences of the investigation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Service d'ophtalmologie Hôpital Pellegrin CHU de Bordeaux Bordeaux France 33000

Sponsors and Collaborators

  • University Hospital, Bordeaux

Investigators

  • Principal Investigator: Cédric SCHWEITZER, MD, University Hospital Bordeaux, France

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Bordeaux
ClinicalTrials.gov Identifier:
NCT01849536
Other Study ID Numbers:
  • CHUBX 2012/20
First Posted:
May 8, 2013
Last Update Posted:
Nov 25, 2013
Last Verified:
Nov 1, 2013

Study Results

No Results Posted as of Nov 25, 2013